Cochrane Abstracts
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436603/all/Recombinant_interferon_beta_or_glatiramer_acetate_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis.
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436603/all/Recombinant_interferon_beta_or_glatiramer_acetate_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis. Accessed January 19, 2025.
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436603/all/Recombinant_interferon_beta_or_glatiramer_acetate_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis
Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436603/all/Recombinant_interferon_beta_or_glatiramer_acetate_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
ID - 436603
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436603/all/Recombinant_interferon_beta_or_glatiramer_acetate_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
